Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Stock Short Interest Report for October

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a significant increase in short interest in October. As of October 30th, there was short interest totaling 127 shares, an increase of 353.6% from the October 15th total of 28 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 2,797 shares, the short-interest ratio is presently 0.0 days.

Innovator IBD Breakout Opportunities ETF Trading Up 0.5%

BOUT stock traded up $0.20 during trading on Friday, reaching $39.24. 1,018 shares of the stock were exchanged, compared to its average volume of 3,389. The business has a 50 day moving average price of $42.17 and a 200-day moving average price of $43.40. Innovator IBD Breakout Opportunities ETF has a 1 year low of $35.05 and a 1 year high of $49.41. The firm has a market capitalization of $13.73 million, a price-to-earnings ratio of 17.56 and a beta of 1.04.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.